Daniel Chard compensation by year
MEDIFAST Summary Compensation Table · all 10 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Salary | $172,268 | $650,000 | $675,000 | $842,596 | $909,173 | $914,291 | $980,624 | $1,000,000 | $1,000,000 | $1,000,000 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $17,847 | $0 | $0 | — | — |
| Stock awards | $2,582,603 | $0 | $0 | $2,629,465 | $2,865,825 | $3,484,918 | $4,002,009 | $4,604,755 | $4,029,669 | $4,567,664 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $154,375 | $884,000 | $1,350,000 | $1,155,150 | $1,751,000 | $2,134,469 | $943,000 | $1,322,500 | $563,500 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $88,193 | $88,197 | $193,375 | $42,782 | $22,876 | $379,111 | $14,603 | $111,807 | $16,686 | $16,886 |
| Total | $2,997,438 | $1,622,197 | $2,218,375 | $4,669,993 | $5,548,874 | $6,930,637 | $5,940,235 | $7,039,062 | $5,609,855 | $5,584,551 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MEDIFAST INC DEF 14A filed April 6, 2026, accession 0001628280-26-023890, and prior-year filings. Open the filing on EDGAR.
How this page was built: the MEDIFAST INC filed document, accession 0001628280-26-023890. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 187,430 | $2,001,752 | — |
| RSU | 124,953 | $1,334,498 | — |
| PSU | 67,631 | $722,299 | — |
| RSU | 30,058 | $321,019 | — |
| RSU | 5,603 | $59,840 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in MEDIFAST INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
MEDIFAST’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Daniel Chard · this page | Chairman & Chief Executive Officer | $5,584,551 |
| Anthony Tyree | Former Chief Business Operations Officer | $1,484,720 |
| James Maloney | Chief Financial Officer | $1,428,396 |
| Nicholas Johnson | Chief Field Operations Officer | $1,195,619 |
| Jason Groves | Chief Legal Officer & Corporate Secretary | $1,160,452 |
Board service
MEDIFAST board · FY2023–FY2025How this board is paid
Company policy: MEDIFAST pays directors a $65,000 cash retainer. As stated in MEDIFAST's FY2025 proxy.
Committees
Executive (Chair)
The full MEDIFAST compensation record
free company briefThis page is one person within MEDIFAST's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the MEDIFAST proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order MEDIFAST's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MEDIFAST's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order MED
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.